Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 88

Sort by

Sort Order Select

Journal Articles

Novel agents and immune invasion in Hodgkin lymphoma

Reid W. Merryman, Ann LaCasce

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 243–248.

https://doi.org/10.1182/hematology.2019000029

Published: 2019

Journal Articles

Opportunities for immunotherapy in childhood acute myeloid leukemia

Adam J. Lamble, Sarah K. Tasian

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 218–225.

https://doi.org/10.1182/hematology.2019000357

Published: 2019

Journal Articles

Targeting CD20: teaching an old dog new tricks

Jeff P. Sharman

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 273–278.

https://doi.org/10.1182/hematology.2019000031

Published: 2019

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Myeloma: next generation immunotherapy

Adam D. Cohen

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 266–272.

https://doi.org/10.1182/hematology.2019000068

Published: 2019

Journal Articles

Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?

Pamela Blair Allen, Ann S. LaCasce

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 249–251.

https://doi.org/10.1182/hematology.2019000077

Published: 2019

Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.

https://doi.org/10.1182/hematology.2019000017

Published: 2019

Journal Articles

Where does PD-1 blockade fit in HL therapy?

Alex F. Herrera

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 213–220.

https://doi.org/10.1182/asheducation-2018.1.213

Published: 2018

Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.

https://doi.org/10.1182/asheducation-2018.1.185

Published: 2018

Journal Articles

Drug-associated thrombocytopenia

Tamam Bakchoul, Irene Marini

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 576–583.

https://doi.org/10.1182/asheducation-2018.1.576

Published: 2018

Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.

https://doi.org/10.1182/asheducation-2018.1.9

Published: 2018

Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 400–405.

https://doi.org/10.1182/asheducation-2017.1.400

Published: 2017

Journal Articles

HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities

Douglas E. Gladstone, Maria P. Bettinotti

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 645–650.

https://doi.org/10.1182/asheducation-2017.1.645

Published: 2017

Journal Articles

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Lewis B. Silverman

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 259–264.

https://doi.org/10.1182/asheducation-2017.1.259

Published: 2017

Journal Articles

Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy

Marie Scully

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 651–659.

https://doi.org/10.1182/asheducation-2017.1.651

Published: 2017

Journal Articles

Non–chemotherapy drug–induced neutropenia: key points to manage the challenges

Brian R. Curtis

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 187–193.

https://doi.org/10.1182/asheducation-2017.1.187

Published: 2017

Journal Articles

Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma

Craig Moskowitz

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 331–338.

https://doi.org/10.1182/asheducation-2016.1.331

Published: 2016

Journal Articles

Advances and practical use of monoclonal antibodies in multiple myeloma therapy

Hans C. Lee, Donna M. Weber

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 512–520.

https://doi.org/10.1182/asheducation-2016.1.512

Published: 2016

Journal Articles

Pure red cell aplasia

Robert T. Means, Jr

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 51–56.

https://doi.org/10.1182/asheducation-2016.1.51

Published: 2016

Journal Articles

Warm antibody autoimmune hemolytic anemia

Theodosia A. Kalfa

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 690–697.

https://doi.org/10.1182/asheducation-2016.1.690

Published: 2016

NARROW

Novel agents and immune invasion in Hodgkin lymphoma

Opportunities for immunotherapy in childhood acute myeloid leukemia

Targeting CD20: teaching an old dog new tricks

Indolent lymphomas: pushing the pace with novel agents

Myeloma: next generation immunotherapy

Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?

Moving immunotherapy into the front line in ALL

Where does PD-1 blockade fit in HL therapy?

Where to start? Upfront therapy for follicular lymphoma in 2018

Drug-associated thrombocytopenia

Antibody-based therapies in patients with acute lymphoblastic leukemia

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunities

Incorporation of nonchemotherapeutic agents in pediatric acute lymphoblastic leukemia

Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy

Non–chemotherapy drug–induced neutropenia: key points to manage the challenges

Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma

Advances and practical use of monoclonal antibodies in multiple myeloma therapy

Pure red cell aplasia

Warm antibody autoimmune hemolytic anemia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only